Viewing Study NCT06624228


Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-03-13 @ 3:33 AM
Study NCT ID: NCT06624228
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
Sponsor: UCB Biopharma SRL
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriatic Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bimekizumab View
None risankizumab View
None arthritis View